Withus Pharmaceutical Co (XKRX:330350) Ending Cash Position : ₩10,844 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Withus Pharmaceutical Co Ending Cash Position?

Withus Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ₩10,844 Mil.

Withus Pharmaceutical Co's quarterly Ending Cash Position increased from Mar. 2024 (₩7,333 Mil) to Jun. 2024 (₩7,654 Mil) and increased from Jun. 2024 (₩7,654 Mil) to Sep. 2024 (₩10,844 Mil).

Withus Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (₩13,831 Mil) to Dec. 2022 (₩9,012 Mil) but then increased from Dec. 2022 (₩9,012 Mil) to Dec. 2023 (₩9,173 Mil).

Withus Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Withus Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Withus Pharmaceutical Co Ending Cash Position Chart

Withus Pharmaceutical Co Annual Data

Trend

Jun19

Jun20

Dec21

Dec22

Dec23

Ending Cash Position

5,576.50

25,146.08

13,830.51

9,011.85

9,173.36

Withus Pharmaceutical Co Quarterly Data
	Sep19	Mar20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial													14,856.66	9,173.36	7,332.92	7,654.27	10,843.61

Withus Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Withus Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9011.848	+	161.507
	=	9,173

Withus Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7654.265	+	3189.344
	=	10,844

Withus Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Withus Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Withus Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Withus Pharmaceutical Co Ltd (XKRX:330350) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

9 Dongsan-ro 12-gil, Seocho-gu, 3rd, 4th, and 5th Floors of Withers Building, Seoul, KOR

Website

http://www.withuspharm.com

Withus Pharmaceutical Co Ltd is a pharmaceutical company. The firm is engaged in the manufacturing and selling of various medicines such as Broazette long-acting tablet, Wipina tablets, Mantini tablets, and Choline syrup among others.

Withus Pharmaceutical Co Headlines

No Headlines